Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02738411

Influence of Intestinal Microbiota Implantation in Preterm Infants on Microbiota and Immune Orientation at 3 Years

Influence of Intestinal Microbiota Implantation Parameters in the Neonatal Period in Premature Infants on Microbiota Profiles and Immune Orientation at 3 Years of Age

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
1 Day
Healthy volunteers
Not accepted

Summary

The main objective of this research is to study the links between changes in the intestinal microbiota (in terms of diversity) during the first 6 weeks of life for preterm infants and the presence / absence of a TH1 immune status at 36 months of age.

Detailed description

The secondary objectives are to study the links between changes of the intestinal microbiota premature infants in terms of: * changing diversity of the microbiota in the first 6 weeks of life; * changes in the bacterial community (UniFrac study) during the first 6 weeks of life; * diversity of the microbiota up to 6 weeks; -AND- * diversity of the microbiota at 1, 2 \& 3 years; * bacterial communities (UniFrac study) at 1, 2 \& 3 years; * lymphocyte subpopulation profiles at 3 years; * serum immunoglobulin A, G, M, E levels at 3 years; * history of infectious episodes, allergic and inflammatory episodes during the first 3 years of life. The links between certain variables known in the literature and neonatal microbiota will be confirmed / studied in our population: * mode of delivery; * length (and type) of antibiotic therapy in the neonatal period; * duration of breastfeeding.

Conditions

Timeline

Start date
2017-05-12
Primary completion
2022-11-28
Completion
2025-12-30
First posted
2016-04-14
Last updated
2025-11-17

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02738411. Inclusion in this directory is not an endorsement.